Sartorius

Photo
14.05.2024 • News

Sartorius and Sanofi Collaborate to Boost Downstream Process Efficiency

Life science group Sartorius and biopharmaceutical firm Sanofi are partnering to create a platform for continuous downstream bioprocessing. Sartorius will use its engineering and manufacturing skills to commercialize integrated and continuous biomanufacturing (ICB) platforms, using Sanofi’s prototypes. In exchange, Sanofi will provide Sartorius with exclusive access to its ICB platform knowledge and patents.

Photo
15.08.2022 • News

Sartorius to Acquire Albumedix for £415 Million

Göttingen, Germany-based life science group Sartorius, through its French-listed subgroup Sartorius Stedim Biotech, plans to acquire all shares of Nottingham, England’s Albumedix, a specialist in recombinant albumin-based solutions, for about £415 million.

Photo
26.05.2021 • Whitepaper

Analytical Testing of Cosmetics

Cosmetic products often consist of a long list of ingredients, including potentially harmful substances. The identification and precise quantification of these substances is crucial to ensure the quality and safety of cosmetics.

Photo
12.05.2020 • News

Sartorius Closes Danaher Acquisition

German pharma and laboratory equipment supplier Sartorius completed its $825 million purchase of certain life science businesses of Danaher Corps at the end of April.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.